Adverum Biotechnologies Statistics
Total Valuation
ADVM has a market cap or net worth of $79.67 million. The enterprise value is $10.93 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADVM has 20.80 million shares outstanding. The number of shares has increased by 70.02% in one year.
| Current Share Class | 20.80M |
| Shares Outstanding | 20.80M |
| Shares Change (YoY) | +70.02% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 11.84% |
| Owned by Institutions (%) | 49.43% |
| Float | 12.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 74.67 |
| Forward PS | n/a |
| PB Ratio | 0.63 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.82, with a Debt / Equity ratio of 0.51.
| Current Ratio | 5.82 |
| Quick Ratio | 5.54 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.26% and return on invested capital (ROIC) is -32.50%.
| Return on Equity (ROE) | -76.26% |
| Return on Assets (ROA) | -29.83% |
| Return on Invested Capital (ROIC) | -32.50% |
| Return on Capital Employed (ROCE) | -49.77% |
| Revenue Per Employee | $8,264 |
| Profits Per Employee | -$777,777 |
| Employee Count | 121 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.06% in the last 52 weeks. The beta is 1.13, so ADVM's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -73.06% |
| 50-Day Moving Average | 4.49 |
| 200-Day Moving Average | 6.24 |
| Relative Strength Index (RSI) | 37.37 |
| Average Volume (20 Days) | 140,272 |
Short Selling Information
The latest short interest is 1.48 million, so 7.12% of the outstanding shares have been sold short.
| Short Interest | 1.48M |
| Short Previous Month | 1.49M |
| Short % of Shares Out | 7.12% |
| Short % of Float | 11.79% |
| Short Ratio (days to cover) | 7.76 |
Income Statement
In the last 12 months, ADVM had revenue of $1.00 million and -$94.11 million in losses. Loss per share was -$5.51.
| Revenue | 1.00M |
| Gross Profit | -67.22M |
| Operating Income | -102.88M |
| Pretax Income | -113.99M |
| Net Income | -94.11M |
| EBITDA | -99.02M |
| EBIT | -102.88M |
| Loss Per Share | -$5.51 |
Full Income StatementBalance Sheet
The company has $153.24 million in cash and $73.26 million in debt, giving a net cash position of $79.98 million or $3.84 per share.
| Cash & Cash Equivalents | 153.24M |
| Total Debt | 73.26M |
| Net Cash | 79.98M |
| Net Cash Per Share | $3.84 |
| Equity (Book Value) | 144.12M |
| Book Value Per Share | 6.93 |
| Working Capital | 133.42M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$85.54 million and capital expenditures -$519,000, giving a free cash flow of -$86.06 million.
| Operating Cash Flow | -85.54M |
| Capital Expenditures | -519,000 |
| Free Cash Flow | -86.06M |
| FCF Per Share | -$4.14 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -10,287.60% |
| Pretax Margin | -9,524.40% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADVM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -70.02% |
| Shareholder Yield | -70.02% |
| Earnings Yield | -103.52% |
| FCF Yield | -94.67% |
Analyst Forecast
The average price target for ADVM is $27.83, which is 626.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.83 |
| Price Target Difference | 626.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 65.61% |
| EPS Growth Forecast (5Y) | -19.29% |
Stock ForecastsStock Splits
The last stock split was on March 21, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Mar 21, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
ADVM has an Altman Z-Score of -5.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.54 |
| Piotroski F-Score | 2 |